Other investigators on the model of hepatocellular carcinoma (HCC) demonstrated, that Robo1 expression promoted tumor angiogenesis and may be considered as an alternative target for anti-angiogenesis treatment [50]. Here, ROBO1 is linked to hepatocellular carcinoma.